Skip to main content
Premium Trial:

Request an Annual Quote

Australian Cancer Center Licenses GenoLogics LIMS to Support NGS Workflows

Premium

Melbourne, Australia-based Peter MacCallum Cancer Center has licensed GenoLogics' Clarity laboratory information management system to support its next-generation and Sanger sequencing workflows, GenoLogics said this week.

Specifically, the center will use Clarity to maintain data integrity and manage its NGS workflows while adhering to regulatory requirements, GenoLogics said.

Andrew Fellowes, who heads molecular diagnostic development at the center, said in a statement that his team chose Clarity after reviewing other systems because of its ability to track patient sample data as well as to enforce clinical workflows.

He said the center will use Clarity's application programming interfaces to connect the new LIMS to its existing laboratory information system and also to its downstream analysis algorithms.

Other Clarity customers who are using the software to support their NGS workflows include Genomic Health (BI 2/22/2013) and Illumina's CLIA laboratory (BI 3/1/2013).

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.